Holen Sie sich die Stockscreener-App
2.42
9.01%
0.20
Handel nachbörslich:
2.43
0.01
+0.41%
C 4 Therapeutics Inc Aktie (CCCC) Neueste Nachrichten
What analysts say about C4 Therapeutics Inc. stockFree Technical Analysis Support - Autocar Professional
C4 Therapeutics Inc. Stock Analysis and ForecastSkyrocketing returns - Autocar Professional
What drives C4 Therapeutics Inc. stock priceHigh-octane investment gains - Autocar Professional
Is C4 Therapeutics Inc. a good long term investmentDouble-digit growth - printweek.in
What analysts say about C4 Therapeutics Inc. stock outlookMinimized Risk Maximum Return - beatles.ru
C4 Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights - ADVFN Brasil
Aardvark Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4) - The Manila Times
C4 Therapeutics Bets On New Cancer Drug And Big Partnerships - Finimize
Molecular Glue Degrader Market Top Companies StudyC4 - openPR.com
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Marriott (MAR) names Jennifer Mason CFO as Kathleen Oberg retires | CCCC SEC FilingForm 4 - Stock Titan
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
C4 Therapeutics (CCCC) Shares Soar 12.06% on FDA Designations - AInvest
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
C4 Therapeutics Stock Surges: What Now? - StocksToTrade
Aligos Therapeutics Grants 2,100 Shares in Stock Options to New Hires with 4-Year Vesting Terms - Stock Titan
C4 Therapeutics, Inc. (NASDAQ:CCCC) Surges 27% Yet Its Low P/S Is No Reason For Excitement - simplywall.st
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Crinetics Pharmaceuticals Announces July 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Top Penny Stocks To Watch In July 2025 - Yahoo Finance
C4 Therapeutics (CCCC) Soars 26.90% on Positive Clinical Trial Results - AInvest
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - PR Newswire
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PR Newswire
Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
C4 Therapeutics, Inc.(NasdaqGS: CCCC) dropped from Russell 3000E Index - MarketScreener
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - PR Newswire
Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
4.91%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):